facebook
twitter
Login
Register
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
MD Brand Connect
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Login
Register
Select Your Interest
Medical Dialogues
Speciality Dialogues
Education Dialogues
Medical Jobs
Medical Matrimony
Login
Register
Home
News
Financial Results
Hospitals & Diagnostics
IT / Health Venture
Implants / Devices
Insurance
Key Movement
Pharmaceuticals
Policy
Technology
pharma-news
blog
Home
News
Takeda sets vote date, aims to close $62 Billion Shire deal Jan. 8
New DRUG options, risk factors added to AHA Heart guidelines, details
Cipla gets USFDA nod for generic version of Voltran Gel
Wockhardt Q2 net loss widens to Rs 23 Crore
USFDA completes inspection of Biocon Bengaluru plant with no observations
AstraZeneca's Diabetic drug Farxiga curbs heart failure, kidney risks
NPPA fixes ceiling price of Volini Max gel
U.S. regulators snip red tape for medical devices to curb opioid crisis
Glenmark to launch phase 1 trial in solid tumours for myeloma drug
Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019
AstraZeneca returns to sales growth, led by cancer medicines
US FDA to strictly monitor sale of flavoured e-cigarettes
Prev
Next
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our
Cookie Policy
and
Cookie Settings.
Ok